LEVIN JEREMY M 13D and 13G filings for Ovid Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:15 pm Sale |
2023-12-31 | 13G | Ovid Therapeutics Inc. OVID |
LEVIN JEREMY M | 6,942,181 9.400% |
-338,940 (-4.66%) |
Filing |
| 2023-02-14 4:01 pm Purchase |
2022-12-31 | 13G | Ovid Therapeutics Inc. OVID |
LEVIN JEREMY M | 7,281,121 10.000% |
726,351 (+11.08%) |
Filing |
| 2022-02-14 4:31 pm Purchase |
2021-12-31 | 13G | Ovid Therapeutics Inc. OVID |
LEVIN JEREMY M | 6,554,770 9.400% |
462,500 (+7.59%) |
Filing |
| 2021-02-16 4:37 pm Purchase |
2020-12-31 | 13G | Ovid Therapeutics Inc. OVID |
LEVIN JEREMY M | 6,092,270 9.600% |
369,337 (+6.45%) |
Filing |